62.4 F
New York
Monday, May 17, 2021

Lucira [NASDAQ: LHDX] COVID-19 Test Kit Reactive to 99.9% of COVID-19 Strains

Must read

Oaktree [NASDAQ: OCSL] Announces Pricing of Underwritten Public Offering

Oaktree Specialty Lending Corporation disclosed that it has set the price of an underwritten public offering of $350.0 million aggregate principal amount of...

Black.one Introduces Cryptocurrency Exchange Venture with $10B in Funding

Black.one has disclosed Tuesday that it has launched Bullish Global. Bullish Global is a subsidiary of Black.one. It is a new blockchain-based cryptocurrency exchange...

Pfizer-BioNTech COVID-19 Vaccine Gets FA Approval for Emergency Use in Adolescents

Pfizer Inc. and BioNTech SE disclosed that its COVID-19 vaccine has got the FDA approval for its COVID-19 vaccine. After the approval,...

Soliton [NASDAQ: SOLY] to be Acquired by Allergan Aesthetics

Soliton, Inc. disclosed Monday that it has inked an agreement with Allergen Aesthetics. As per the agreement, Allergen Aesthetics will buy Soliton. Allergen...

Lucira Health, Inc. [NASDAQ: LHDX] shares skyrocketed more than 18% during the pre-market trading session of Friday after the firm disclosed that its all-in-one COVID-19 test Kit has shown positive reactions towards the identification of COVID-19 strains. The kit has shown 99.9% positive results.

The firm now will be able to recognize the “double mutant” variant of COVID-19 with its molecular test kit. Earlier, on March 24, 2021, the “double mutant” variant was first discovered in India. Additionally, the other mutant was by Stanford Clinical Virology Lab scientists discovered in California on March 25, 2021.

Furthermore, the firm disclosed that it has identified that the test kit has been responsive to more than 99.9% of viral sequences, which are nearly 30,000 letters long. It’s a complex job, but truly crucial since users depend on the LHDX test for accurate results.

About LUCIRA COVID-19 All-In-One Test Kit

The LUCIRA COVID-19 All-In-One Test Kit Test Kit fits into the palm of a hand. It isolates genetic material from the virus and strengthens it comparable to PCR lab tests. Each Lucira test kit includes everything that is required to conduct one COVID-19 test.

Furthermore, the easy-to-use ‘swab, stir and detect’ test platform of LHDX shown that 100% of users successfully carried out the test in fewer than about two minutes of hands-on time in easy-to-use testing.

More articles

Latest article

Elon Musk’s SpaceX to Roll Out Dogecoin-Backed Satellite to the Moon in 2022

Elon Musk’s SpaceX has decided to recognize Dogecoin as payment to roll out its “DOGE-1 Mission to the Moon”. The mission is going to...

SBI CEO Yoshitaka Kitao Reveals Ripple to Go Public after its Legal Battle with the SEC is Over

CEO of Japanese financial services company SBI Holdings, Yoshitaka Kitao disclosed that Ripple has opted for an option to go public once its legal...

Coinbase Pro Announces it will be Listing Internet Computer’s ICP

Coinbase Pro cryptocurrency exchange has disclosed that it has decided to list ICP once it goes live. ICP is the governance token of the...

WISeKey [NASDAQ: WKEY] Gets Investment to finance its TrustNFT.IO NFT Platform

WISeKey International Holding AG disclosed Friday that it has inked a term-sheet to enter into an unsecured short-term loan and the issuance and...

Moderna [NASDAQ: MRNA] Inks Supply Agreement with Switzerland

Moderna, Inc. disclosed that it has inked a supply agreement on Thursday with the Swiss Federal Government. As per the agreement, Moderna Inc...

TeraBlock Will Have its Own BSCPad IDO Soon

TeraBlock which is a project making a platform for automated cryptocurrency portfolio management disclosed that it is preparing for an initial DEX offering (IDO)...

Why Chiasma [NASDAQ: CHMA] Stock is Skyrocketed?

Shares of Chiasma, Inc. surged 46.48% during the trading session of Wednesday. Chiasma has disclosed the financial results for the Q1 completed March...

NeoGenomics [NASDAQ: NEO] Announces Acquisition of Inivata Ltd

NeoGenomics, Inc. revealed Wednesday that it has decided to purchase Inivata Ltd. Inivata will grow into a liquid biopsy-centered division together with increasing...